Is It Time To Reassess Constellation Software (TSX:CSU) After Its Recent Share Price Rebound

  • For investors wondering whether Constellation Software stock at around C$2,931.96 is offering fair value or a potential bargain, this article breaks down what the current price might be implying.
  • The share price has risen 5.7% over the past week and 20.1% over the past month, although it is still down 9.5% year to date and 40.8% over the last year. These moves may have shifted how investors think about both growth potential and risk.
  • Recent coverage has focused on Constellation Software's role as a large Canadian software group that acquires and operates vertical market software businesses, with particular attention on how it continues to deploy capital into new assets. Commentators have also highlighted its long history with this acquisition model, which helps frame today's share price moves in the context of how the company grows over time.
  • On Simply Wall St's valuation checks, Constellation Software scores a 3 out of 6. The sections that follow will compare different ways of looking at value, while keeping an eye on an approach at the end that aims to tie these methods together more clearly.

Find out why Constellation Software's -40.8% return over the last year is lagging behind its peers.

Advertisement

Approach 1: Constellation Software Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model takes estimates of a company’s future cash flows and discounts them back to today’s dollars, aiming to show what those cash flows might be worth right now.

For Constellation Software, the model used here is a 2 Stage Free Cash Flow to Equity approach, based on cash flows in $. The latest twelve month free cash flow (FCF) is about $2,729.9m. Analysts provide explicit forecasts out to 2027, with FCF for 2027 estimated at $3,636.7m. Beyond that, Simply Wall St extrapolates cash flows, with ten year projections ranging from $3,075.7m in 2026 to $5,951.8m in 2035, each adjusted back to today using discount rates to reflect risk and the time value of money.

When these cash flows are added up and combined with a terminal value, the model arrives at an estimated intrinsic value of about $5,697.61 per share. Versus the current share price of roughly C$2,931.96, this implies the stock is about 48.5% below the DCF estimate. This indicates a wide gap between the current market price and this particular assessment of value.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Constellation Software is undervalued by 48.5%. Track this in your watchlist or portfolio, or discover 9 more high quality undervalued stocks.

CSU Discounted Cash Flow as at Jun 2026
CSU Discounted Cash Flow as at Jun 2026

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Constellation Software.

Approach 2: Constellation Software Price vs Earnings

For profitable companies, the P/E ratio is a useful way to think about value because it links what you pay for each share to the earnings that the business is already generating.

What counts as a “normal” P/E depends on how fast earnings are expected to grow and how risky those earnings appear. Higher expected growth or lower perceived risk can justify a higher multiple, while slower growth or higher risk tends to support a lower one.

Constellation Software is currently trading on a P/E of 60.43x. That is above the broader Software industry average of 23.13x, but below the peer group average of 72.43x. Simply comparing those figures, it might look expensive relative to the industry and cheaper than some peers.

Simply Wall St’s Fair Ratio of 32.64x is designed to go a step further. It is a proprietary estimate of what the P/E could be given Constellation Software’s earnings growth profile, industry, profit margins, market cap and key risks. Because it adjusts for those factors, it offers a more tailored benchmark than raw industry or peer comparisons.

Compared with this Fair Ratio, the current P/E of 60.43x is higher, which suggests the stock is trading above that customised estimate of fair value.

Result: OVERVALUED

TSX:CSU P/E Ratio as at Jun 2026
TSX:CSU P/E Ratio as at Jun 2026

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 3 top founder-led companies.

Upgrade Your Decision Making: Choose your Constellation Software Narrative

Earlier it was mentioned that there is an even better way to understand valuation. Narratives take the story you believe about Constellation Software, link it to specific forecasts for revenue, earnings and margins, then translate that into a fair value that you can compare with the current share price to decide whether it looks attractive or stretched.

On Simply Wall St’s Community page, Narratives are an accessible tool used by millions of investors. They let you pick or create a storyline, plug in assumptions, and then see how your valuation reacts as new information, such as AI adoption updates or earnings, flows through the model in real time.

For example, one Constellation Software Narrative anchors on a higher fair value of about C$5,325.57, while a more cautious Narrative points to around C$3,477.92. By viewing both side by side you can decide which set of assumptions feels closer to your own view and what that implies when you compare each fair value with today’s market price.

Do you think there's more to the story for Constellation Software? Head over to our Community to see what others are saying!

TSX:CSU 1-Year Stock Price Chart
TSX:CSU 1-Year Stock Price Chart

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About TSX:CSU

Constellation Software

Acquires, builds, and manages vertical market software businesses to develop mission-critical software solutions for public and private sector markets.

Reasonable growth potential with adequate balance sheet.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1157.5% undervalued
47 users have followed this narrative
2 users have commented on this narrative
7 users have liked this narrative
WE
WealthAP
NOVO B logo
WealthAP on Novo Nordisk ·

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Fair Value:DKK 407.7721.4% undervalued
67 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
VA
ValueInvestingSubstack
ZTS logo
ValueInvestingSubstack on Zoetis ·

Zoetis down -50% over the past year

Fair Value:US$92.9218.9% undervalued
23 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
CE
CentryResearch
LEU logo
CentryResearch on Centrus Energy ·

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

Fair Value:US$19013.7% undervalued
24 users have followed this narrative
0 users have commented on this narrative
10 users have liked this narrative

Updated Narratives

WI
WisetoWealth
PYPL logo
WisetoWealth on PayPal Holdings ·

The Underrated Transformation of a Digital Payments Giant

Fair Value:US$90.3137.8% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BL
Blagget
TERA logo
Blagget on Terra Balcanica Resources ·

The C$4M Explorer Positioned to Become Europe's First Antimony Mine

Fair Value:CA$0.487.5% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DA
CHTR logo
david_6nroa on Charter Communications ·

Charter is undervalued - Here's why.

Fair Value:US$87.0741.6% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.919.1% undervalued
81 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28026.1% undervalued
185 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.6% undervalued
71 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0